Low Level Laser Treatment (LLLT) and Lorcaserin for Weight Management

Inclusion Criteria: * be 18-70 years of age; * have a body weight of greater than 50 kg (110 pounds); * have a BMI 27-39.9 kg/m2; * be weight concerned; * be motivated to reduce their central adiposity; * be able to participate fully in all aspects of the study; * have understood and signed study informed consent. Exclusion Criteria: * have used weight loss medications or participated in a weight loss program within the past 30 days; * are currently taking supplements known to affect weight, such as garcinia cambrogia. * have had weight fluctuations of 20 pounds or more in the past 6 months (self-report); * have an implanted device (including pacemaker or lap band) in the targeted area of LLLT; * have an active untreated clinically significant psychiatric condition (psychosis, bipolar disorder, or depression); * have used an investigational drug within 30 days of study enrollment; * have a recent history (past 30 days) of alcohol or drug abuse or dependence; * are currently pregnant or lactating, or are of child-bearing potential or are likely to become pregnant during the medication phase and are unwilling to use a reliable form of contraception; * have a history of any major cardiovascular events including heart valve disease, cardiac arrhythmias, congestive heart failure, acute coronary syndrome, stroke, transient ischemic attack, or peripheral vascular disease; * have current uncontrolled hypertension (systolic \> 165 mm Hg or diastolic \> 95 mm Hg) documented on 2 separate occasions; * have clinically significant acute or chronic progressive or unstable neurologic, hepatic, renal, cardiovascular, lymphatic, respiratory, or metabolic disease (such as diabetes) or active cancer or are within 1 year of cancer remission; * Prior surgical intervention for body sculpting/weight loss, such as liposuction, abdominoplasty, stomach stapling, lap band surgery, etc.; * medical, physical, or other contraindications for body sculpting/weight loss; * current use of medication(s) known to affect weight levels/cause bloating or swelling and for which abstinence during the course of study participation is not safe or medically prudent; * concurrently taking a serotonergic drug (selective serotonin reuptake inhibitors (SSRIs), serotonin-norepinephrine reuptake inhibitors (SNRIs), monoamine oxidase inhibitors (MAOIs), triptans, bupropion, dextromethorphan, St. John's Wort). These drugs can be used to treat depression and/or migraines but are contraindicated with lorcaserin; * any medical condition known to affect weight levels and/or to cause bloating or swelling; * diagnosis of, and/or taking medication for, irritable bowel syndrome; * active infection, wound or other external trauma to the areas to be treated with the laser; * known photosensitivity disorder; * are allergic to lorcaserin; * current active cancer or currently receiving treatment for cancer; or * have a known history of any condition or factor judged by the investigator to preclude participation in the study or which might hinder adherence;